Register Now: Advances in Spectroscopy for Pharma and Biopharmaceutical Analysis Symposium
News|Videos|March 17, 2025

AAFS 2025: Tom Metz Talks About Current Challenges in Molecular Measurement Science

Author(s)Will Wetzel

In this video clip, Metz discusses his focus on molecular measurement science using mass spectrometry (MS) to study small molecules, emphasizing the challenge of identifying and quantifying unknown compounds.

The 77th Annual American Academy of Forensic Sciences Conference took place in Baltimore, Maryland, last month. Over the course of a week, conference attendees had the opportunity to attend talks related to the various applications, techniques, and disciplines of forensic science. A major focus of the conference was on technology, and how it is currently being used in the industry. Because artificial intelligence (AI) is being integrated into a wide variety of scientific disciplines, several talks and oral symposia focused on this topic, describing how AI is changing the way forensic investigations are being routinely conducted.

Other talks were worth highlighting. Tom Metz, who is a Laboratory Fellow and Chief Science Officer of the Biological Sciences Division at Pacific Northwest National Laboratory, delivered a talk at AAFS titled, “Reference-Free Identification of Fentanyl Analogs.” Recently, Metz sat down with Spectroscopy to discuss his current research, including the major challenges in molecular measurement science currently (1,2).

In this video clip, Metz discusses his focus on molecular measurement science using mass spectrometry (MS) to study small molecules, emphasizing the challenge of identifying and quantifying unknown compounds due to the rarity of obtaining pure forms. He highlights that only a small fraction (less than 1%) of the chemical space is accessible in this way. Metz points out the daily exposure to various chemicals, which can affect health, and expresses a desire to advance mass spectrometry to better understand small molecule interactions in biological samples, suggesting that current methods only scratch the surface of this knowledge.

Metz previously directed core laboratories for major National Institutes of Health (NIH) programs, such as the Undiagnosed Diseases Network and the Environmental Determinants of Diabetes in the Young study (3). From 2021 to 2023, he served as President of the Metabolomics Association of North America (3). Currently, he leads the PNNL m/q Initiative and co-leads the ChemBio Analytical Sciences Hub within the NEXUS Exposome Research Coordination Network (3).

This interview is part of our coverage of AAFS 2025. To check out all our coverage of the AAFS Conference, click here.

References

  1. Wetzel, W. The State of Forensic Science: Previewing an Upcoming AAFS Video Series. Spectroscopy. Available at: https://www.spectroscopyonline.com/view/the-state-of-forensic-science-previewing-an-upcoming-aafs-video-series (accessed 2025-03-14).
  2. Wetzel, W. AAFS 2025: Tom Metz Discusses Applying Metabolomics and Lipidomics in Studying Disease. Spectroscopy. Available at: https://www.spectroscopyonline.com/view/aafs-2025-tom-metz-discusses-applying-metabolomics-and-lipidomics-in-studying-disease (accessed 2025-03-14).
  3. Pacific Northwest National Laboratory, Thomas O. Metz. PNNL.gov. Available at: https://www.pnnl.gov/people/thomas-o-metz (accessed 2025-03-17).

Related to this article

Abstract concept of connecting molecules DNA network vector neurons | Image Credit: © bill2499 - stock.adobe.com
Garth Simpson of Purdue University outlines plans to survey more ordered molecular assemblies and to apply interface-specific chiral spectroscopy to enzyme reactors, solid-phase synthesis, spin-selective reactions, and, ultimately, a new analytical method.
Healthcare administrator reviewing an insurance policy schedule with a stethoscope on a clipboard, health insurance coverage, medical underwriting, prior authorization, and patient claims processing. | Image Credit: Joi_studio - stock.adobe.com
In a SciX interview, Marc Porter covered a lot of ground, from a student-driven pivot into immunoassays to a baseball analogy for Stokes and anti-Stokes scattering, and shares the open questions he is still chasing.